This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2000 Remove Legalization Remove Microdosing Related Topics
Clinical Trials Decriminalization Seed-To-Sale Treatment Conditions Policy Access Terpenes Patients Sleep More Related Topics >
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. Connecticut Gov.

Clinical Trials 98
Clinical Trials Therapy Decriminalization Treatment 98
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. Andrew is a supporter of legalizing psychedelic drugs and has been vocal about his intentions if he were to assume a government office. in/andrewyangvfa/ [link]. Robin Carhart-Harris. in/ronanlevy/.

Research and Development 51
Research and Development Medicine Treatment Pharmaceutical 51
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024